Study wrapper · #236
Advances in the detection of growth hormone releasing hormone synthetic analogs.
Editor's note
An anti-doping study combining in-vitro metabolism with method development. The researchers incubated four larger GHRH analogues, sermorelin, tesamorelin, CJC-1295, and CJC-1295 with drug affinity complex, under conditions mimicking metabolism, identified 19 major metabolites, then synthesised those as reference materials to build a sensitive detection method for demonstrating GHRH use in urine (detection limits generally 1 ng/mL or less). The authors note that although intelligence and admissions suggest these peptides are used, they have rarely been found in tested samples, partly because of low urinary concentrations and poorly understood metabolism, which this work directly addresses. For readers, the GHRH analogues appear as forensic targets; the study reports how they break down and how to detect them, not whether they produce any benefit. There is no efficacy, dosing, or safety evidence about Tesamorelin, Sermorelin, or CJC-1295 here. This is analytical and metabolism work, not clinical evidence.
Plain-language abstract
This study aimed to improve detection of banned growth-hormone-releasing peptides by first understanding how the body breaks them down. The researchers took four of the larger peptides in this class, sermorelin, tesamorelin, CJC-1295, and a long-acting form of CJC-1295, and exposed them to laboratory conditions that mimic how the body processes drugs. They identified 19 major breakdown products, then chemically made pure versions of these to use as reference standards. Using those standards, they developed a sensitive mass-spectrometry method to detect both the original peptides and their breakdown products in urine, generally down to about 1 nanogram per millilitre. The researchers explained that these peptides have rarely been caught in doping tests, possibly because they occur at very low levels and their breakdown was poorly understood, gaps this work helps close. The study is about detecting these substances and understanding how they break down; it does not test their effects, benefits, or safety in people.